Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial

Gastroenterology
Marc LémannGroupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID)

Abstract

The aim of this study was to evaluate the usefulness of short-term infliximab combined with azathioprine (AZA) or 6-mercaptopurine (6-MP) in steroid-dependent Crohn's disease patients. Patients with active disease despite prednisone given for more than 6 months were eligible and were stratified as follows: the failure stratum consisted of patients receiving AZA/6-MP at a stable dose for more than 6 months, and the naive stratum consisted of patients not treated previously with AZA/6-MP. Patients were randomized to infliximab 5 mg/kg or placebo at weeks 0, 2, and 6. All patients were treated with AZA/6-MP maintained at a stable dose throughout the 52 weeks of the study. The primary end point was remission off steroids at week 24. Among the 113 enrolled patients (55 in the failure stratum), 57 were assigned to infliximab. At week 24, the success rate (intent-to-treat analysis) was higher in the infliximab group than in the placebo group (57% vs 29%; P = .003); at weeks 12 and 52, the corresponding rates were 75% vs 38% (P < .001) and 40% vs 22% (P = .04), respectively. In each stratum, the success rate was significantly higher in the infliximab group at weeks 12 and 24, and a trend was found at week 52. In the failure stratum, on...Continue Reading

Citations

Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Jun 15, 2010·Nucleosides, Nucleotides & Nucleic Acids·S Almer
Aug 19, 2007·Gut·Julián Panés, Subrata Ghosh
Feb 2, 2008·Digestion·Pierre MichettiFlorian Froehlich
May 8, 2008·World Journal of Gastroenterology : WJG·Amandeep K Shergill, Jonathan P Terdiman
Jan 18, 2008·World Journal of Gastroenterology : WJG·Patricia L Kozuch, Stephen B Hanauer
Sep 24, 2008·World Journal of Gastroenterology : WJG·María Josefina EtcheversMiquel Sans
Sep 24, 2008·World Journal of Gastroenterology : WJG·Elena RicartJulián Panés
Sep 24, 2008·World Journal of Gastroenterology : WJG·Edouard LouisC Reenaers
Apr 17, 2010·World Journal of Gastroenterology : WJG·Francesca VincenziGian Luigi de' Angelis
Sep 25, 2012·World Journal of Gastroenterology : WJG·Alan B R ThomsonHugh J Freeman
May 30, 2013·World Journal of Gastroenterology : WJG·Burton I Korelitz
Mar 8, 2013·World Journal of Gastroenterology : WJG·Pascal FreiGerhard Rogler
Jan 15, 2014·World Journal of Gastroenterology : WJG·Mindy C W LamBrian Bressler
Nov 19, 2013·Journal of Comparative Effectiveness Research·Sara RennaMario Cottone
Aug 27, 2009·Biologics : Targets & Therapy·Renato CavigliaMichele Cicala
Feb 20, 2014·The Journal of Dermatological Treatment·G GirolomoniC Paul
Sep 4, 2015·Scandinavian Journal of Gastroenterology·Martin BortlikMilan Lukas
Dec 19, 2015·Expert Review of Clinical Pharmacology·A S StrikM Löwenberg
Aug 8, 2014·Expert Review of Gastroenterology & Hepatology·Ole Haagen NielsenGerhard Rogler
Oct 13, 2011·Expert Opinion on Pharmacotherapy·Mario CottoneFilippo Mocciaro
Apr 2, 2014·Expert Review of Gastroenterology & Hepatology·Lauren BeswickMiles P Sparrow
Nov 13, 2015·Expert Opinion on Drug Safety·Itishree Trivedi, Stephen B Hanauer
Jan 24, 2014·Expert Opinion on Biological Therapy·Klaus R HerrlingerKlaus Fellermann
Nov 12, 2013·Expert Opinion on Biological Therapy·Thomas BillietSéverine Vermeire
Jul 28, 2015·Expert Opinion on Biological Therapy·Mahmoud H Mosli, Brian G Feagan
Jun 3, 2014·Current Medical Research and Opinion·Sunanda V KaneDavid A Schwartz
Jan 23, 2016·Expert Opinion on Drug Safety·Konstantinos PapamichaelLaurent Peyrin-Biroulet
Jul 15, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Anne JarryChristian L Laboisse
Nov 25, 2014·Expert Opinion on Pharmacotherapy·Andrea AffrontiMario Cottone
Oct 13, 2007·Expert Opinion on Pharmacotherapy·A R Bremner, R M Beattie
Dec 9, 2010·Arquivos De Gastroenterologia·UNKNOWN Brazilian Study Group of Inflammatory Bowel Diseases
Apr 15, 2017·Inflammatory Bowel Diseases·Yehyun ParkUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases (KASID)
Apr 13, 2010·Expert Review of Clinical Immunology·Xenofon Baraliakos, Juergen Braun
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Remo Panaccione, Subrata Ghosh
Jan 8, 2015·Journal of Pediatric Gastroenterology and Nutrition·Jarosław KierkuśMałgorzata Sładek
Jul 8, 2017·Pharmacogenomics·Sara RufiniPaola Borgiani
Nov 5, 2015·United European Gastroenterology Journal·Justin Côté-DaigneaultPierre Poitras

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.